2 Methods A comprehensive review of the literature was conducted from July 2024 to October 2024, encompassing a wide range of research methodologies, including observational studies, randomised and non-randomised clinical trials, experimental studies, case reports, and case series
10.1101/cshperspect.a018903 Cold Spring Harb
Regulatory Status in 2026 Despite growing interest in the compound, GHK-Cu is not an FDA-approved therapy for any health issue
The Regenerative Trio Stack (BPC-157 + NAD+ + GHK-Cu) is designed to help your body: Repair
Semaglutide (Ozempic/Wegovy) legal status Current legal status: FDA-approved for diabetes and obesity Completely legal with prescription Illegal to possess without prescription Not a controlled substance (no DEA scheduling) Prescription pathways: Traditional doctor visit (endocrinologist, primary care) Telehealth prescription services (Ro, Calibrate, Found, etc.) Compounded semaglutide from licensed compounding pharmacies Research chemical semaglutide: Some companies sell non-FDA-approved semaglutide as research chemical Legal gray area similar to BPC-157 Quality and purity concerns (no FDA oversight) Prescription versions are safer and more reliable See our semaglutide vs tirzepatide guide for prescription options
)
.webp)
